FindTrial
Sign In

Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil for obese patients undergoing gastroscopy with nasopharyngeal airway device: a ranomized controlled trial

Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil for obese patients undergoing gastroscopy with nasopharyngeal airway device: a ranomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029918
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-02-24
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric disease

Interventions

Group 1:dexmedetomidie and remifentanil
Group 2:propofol and remifentanil

Sponsors

Shandong Cancer Hospital and Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Male or female aged 18-65 years; BMI >= 30kg/m2.

Exclusion criteria

Exclusion criteria: Coagulopathy or nose bleeding; severe cardiac, pulmonary, hepatic or renal disease; infection of the mouth,nose,or throat.

Design outcomes

Primary

MeasureTime frame
advancing scopeinto throat;incidence of hypoxemia;—

Secondary

MeasureTime frame
endoscopist's satisfaction;patients' satisfaction of sedation;—

Countries

China

Contacts

Public ContactWang Xiuqin

Shandong Cancer Hospital and Institute

jasmine75@163.com+86 13665416586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026